Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis : An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)

THAOS Investigators2026-01-092026-01-092025-03THAOS Investigators 2025, 'Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis : An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)', Journal of Cardiac Failure, vol. 31, no. 3, pp. 525-533. https://doi.org/10.1016/j.cardfail.2024.06.0031071-9164https://hdl.handle.net/10641/7079Publisher Copyright: © 2024 The Authors9448347enginfo:eu-repo/semantics/openAccessTransthyretin amyloid cardiomyopathyreal-worldsurvivaltafamidisCardiology and Cardiovascular MedicineSDG 3 - Good Health and Well-beingJournal ArticleYesyesSurvival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis : An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article10.1016/j.cardfail.2024.06.003https://www.scopus.com/pages/publications/85200436488https://www.scopus.com/pages/publications/85200436488#tab=citedBy